sglt2 glp-1 news Use of Receptor Agonists and Inhibitors Among Patients with Type 1 Diabetes: A Nationwide Register-Based Cohort Study GLP-1 and SGLT2 inhibitors show

Saxenda and Victoza both contain the same active drug, liraglutide

Choosing where to have your treatment matters just as much as choosing which treatment to have

The study reported that Ozempic resulted in a significant reduction in the risk of kidney disease-related events

If you are ineligible for one of our Plans, we offer alternative Wellness Plans to help you manage and lose weight

Our results show they reduce the risk of headache over time, with a notable risk reduction of 31% at 3 months (RR: 0.69) and a sustained, significant effect at 24 months (RR: 0.80)

At Endocare, the medication is matched to the patients phenotype, weight category, lifestyle, and medical history, then supported by nutrition, body-composition tracking, and lifestyle coaching from our clinical nutritionist